Rovin Capital’s Pfizer PFE Stock Holding History

Rovin Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$276K	Sell	11,094 -14,284	-56%	-$360K	0.07%	179
2025 Q3	$647K	Sell	25,378 -1,284	-5%	-$31.7K	0.18%	94
2025 Q2	$646K	Sell	26,662 -1,845	-6%	-$43K	0.2%	82
2025 Q1	$722K	Buy	28,507 +4,303	+18%	+$113K	0.23%	74
2024 Q4	$642K	Sell	24,204 -3,257	-12%	-$88.3K	0.23%	74
2024 Q3	$795K	Buy	27,461 +4,139	+18%	+$121K	0.29%	71
2024 Q2	$653K	Buy	23,322 +3,652	+19%	+$101K	0.27%	72
2024 Q1	$546K	Buy	19,670 +3,862	+24%	+$107K	0.22%	91
2023 Q4	$455K	Buy	15,808 +1,477	+10%	+$44.6K	0.21%	93
2023 Q3	$475K	Buy	14,331 +5,977	+72%	+$211K	0.22%	62
2023 Q2	$306K	Buy	+8,354	New	+$325K	0.14%	105
2022 Q1	–	Sell	-10,184	Closed	-$601K	–	129
2021 Q4	$601K	Buy	+10,184	New	+$505K	0.29%	61

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Rovin Capital's PFE Position: Q4 2025 in Review

Rovin Capital reduced its Pfizer (PFE) stake by 56% in Q4 2025, selling an estimated $360K and leaving 11,094 shares worth $276K. The position accounts for 0.07% of the portfolio, ranked #179.

Rovin Capital first reported a position in PFE in Q4 2021 and has held it in 12 quarters since. The position peaked at $795K in Q3 2024. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Rovin Capital held 11,094 shares of Pfizer worth $276K as of Q4 2025.
Rovin Capital sold 14,284 Pfizer shares in Q4 2025, an estimated $360K.
Pfizer made up 0.07% of Rovin Capital's portfolio in Q4 2025, its #179 holding.
Rovin Capital first reported a position in Pfizer in Q4 2021 and has held it in 12 quarters since.
Rovin Capital's Pfizer position peaked at $795K in Q3 2024.
2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.